The Efficacy and Safety of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Combined With Thymosin in Advanced Non-Small Cell Lung Cancer Patients Harboring Active Epidermal Growth Factor Receptor Mutations

OBJECTIVE: To explore the efficacy and safety of EGFR-TKI combined with thymosin therapy in advanced non-small cell lung cancer (NSCLC) patients harboring active EGFR mutations. METHODS: Patients confirmed as advanced NSCLC with active EGFR mutations were recruited from August 2008 to July 2018 retr...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Front Oncol
Hlavní autoři: Feng, Yongdong, Zhu, Guangkuo, Lang, Song, Hao, Ping, Li, Guanghui, Chen, Fanglin, Zhuo, Wenlei, Duan, Yuzhong, Zhang, Anmei, Chen, Zhengtang, Sun, Jianguo
Médium: Artigo
Jazyk:Inglês
Vydáno: Frontiers Media S.A. 2021
Témata:
Oncology
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8195272/
https://ncbi.nlm.nih.gov/pubmed/34123814
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2021.659065
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky